Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors

Clinical trial NCT05372640 · RECRUITING

Trial details

NCT number: NCT05372640
Sponsor: National Cancer Institute (NCI)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage IV Breast Cancer AJCC v8 Metastatic Breast Carcinoma Metastatic Malignant Solid Neoplasm Metastatic NUT Carcinoma Unresectable Breast Carcinoma Unresectable Malignant Solid Neoplasm Unresectable NUT Carcinoma

Start date: 2023-08-10
Primary completion: 2027-06-07
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.